Leritrelvir
Leritrelvir (RAY1216) is an orally active SARS-CoV-2 main protease slow-tight inhibitor with a Ki of 8.6 nM[1].
Product Specifications
CAS Number
[2923310-64-7]
Product Name Alternative
RAY1216
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/leritrelvir.html
Purity
99.17
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(C(F)(F)F)N[C@H](C(N1C[C@H](CCC2)[C@H]2[C@H]1C(N[C@@H](C[C@]3([H])CCNC3=O)C(C(NC4CCCC4)=O)=O)=O)=O)C5CCCCC5
Molecular Formula
C31H44F3N5O6
Molecular Weight
639.71
References & Citations
[1]Chen X, et al. Inhibition mechanism and antiviral activity of an α-ketoamide based SARS-CoV-2 main protease inhibitor. bioRxiv, 2023: 2023.03. 09.531862.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15158109 1 Vial
Lentiviral human C2orf81 shRNA (UAS) - Lentiviral human C2orf81 shRNA (UAS, GFP) (100)
Ask
View Details 